Canine leptospirosis is caused by bacteria spread in the urine of infected animals. Leptospirosis is a serious infectious bacterial disease of dogs and a zoonotic risk to humans. Whilst a range of serovars may lead to disease in dogs, Nobivac Lepto2 provides cover against the two serogroups most commonly implicated in clinical cases within the UK.
Aqueous suspension for injection
Per dose of 1 ml
Inactivated Leptospira interrogans serogroup
- Canicola; strain Ca-12-000: 957 - 1676 ELISA Units*
- Icterohaemorrhagiae; strain 820K: 625 - 1335 ELISA Units
* Antigen mass ELISA Units, in vitro potency test according to Ph.Eur. monograph 0477.
Indications for use
Nobivac Lepto 2 is indicated for the active immunisation of dogs to reduce infection with Leptospira interrogans serogroup canicola and Leptospira interrogans serogroup icterohaemorrhagiae.
The duration of immunity induced by the vaccine was established as at least one year.
Nobivac Lepto 2 significantly reduces the number of animals which develop a urinary tract infection which can predispose to development of a carrier condition after L. canicola and L. icterohaemorrhagiae infection.
APET-Plastic trays of 10 and 50 single dose vials
For full information please refer to the product data sheet. Further information is available on request.
Use Medicines Responsibly. For more information please refer to the Responsible Use sections of the NOAH website.
If you are not the prescribing veterinary surgeon, advice should be sought from the medicine prescriber.
Date of preparation: January 2018